Some good news amid all the view well India's covid 19 vaccine candidate co vaccine has received the approval of the drug regulator D CGI for the phase one and phase two of huaman clinical trials the drug has been developed y the Hyderabad based Bharat biotech. Human clinical trials for which i should do to start across india in july 2020.
The vaccine candidate has been developed in collaboration with the indian council of medical research and national Institute of virology Pune . The SARS cove - strain was isolated in NIV pune transferred to bharath biotech the iactivated vaccine has shown promise in preclinical demonstrating extensive safety and effective immune responses inactivated vaccine has been developed and manufactured at bharath biotech. High containment facility located in the genome valley in Hyderabad .
So what is an inactivated vaccine well the process involves growing the virus on a large scale and killing or in activating the virus with a chemical once the vaccine is injected into a human body it has no potential to infect or replicate since it is a killed virus it helps the immune system mount an antibody response towards of the virus apart from DCG co vaccine has got the approval from CD SEO or Central drug control organization ministry of Health and family welfare to begin the human clinical trials after the companies submitted results generated from pre clinical studiess demonstrating safety and immune response at present no confirm information is available as to when the vaccine will be available in the market for the human use apart co vaccine many other vaccines by indian and global firms are being developed currently in may the government said that as many as 30 groups where working on their vaccines of which fiber in advanced stages a top scientific advisor to the government also said that efforts that normally took 15 years were actually being condensed to a 12 month period.